Deep Track Capital, LP Viridian Therapeutics, Inc.\De Transaction History
Deep Track Capital, LP
- $2.82 Billion
- Q2 2025
A detailed history of Deep Track Capital, LP transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Deep Track Capital, LP holds 5,380,449 shares of VRDN stock, worth $98.8 Million. This represents 2.67% of its overall portfolio holdings.
Number of Shares
5,380,449
Previous 5,380,449
-0.0%
Holding current value
$98.8 Million
Previous $72.5 Million
3.71%
% of portfolio
2.67%
Previous 2.54%
Shares
13 transactions
Others Institutions Holding VRDN
# of Institutions
184Shares Held
82.7MCall Options Held
78.9KPut Options Held
417K-
Commodore Capital LP New York, NY4.88MShares$89.6 Million6.35% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$87.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.51MShares$82.8 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.43MShares$81.3 Million7.39% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$71.3 Million10.75% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $733M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...